Meeting Information - The shareholder meeting is scheduled for July 3, 2025, at 14:30 [1] - The meeting will be held at the office building of Sandam Technology Park, Xiamen, Fujian Province [1] - Voting will be conducted through both on-site and online methods [1] Voting Procedures - The online voting system used will be the Shanghai Stock Exchange's shareholder meeting online voting system [2] - Voting will be available from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders must complete identity verification to vote online for the first time [2] Attendance and Registration - Shareholders registered by the close of trading on June 26, 2025, are eligible to attend [4] - Registration for the meeting will take place on July 2, 2025, from 9:00 to 16:00 [4][5] - Proxy representatives can attend the meeting but must present valid identification and authorization documents [4][5] Meeting Agenda - The agenda includes non-cumulative voting proposals approved by the board [2] - No related party shareholders are required to abstain from voting [2] Contact Information - The company can be contacted at the office address in Xiamen, Fujian Province, for any inquiries related to the meeting [6]

Core Viewpoint - The company, Sanda Membrane, is planning to launch an H-share listing in Hong Kong to expand its capital base and address growth challenges, particularly in its membrane technology and water treatment sectors [2][7][9]. Group 1: Company Background and Financial Performance - Sanda Membrane was founded by Blue Weiguang and has a history of capital market activities, including listings in Singapore and A-shares in China [3]. - The company reported revenue growth from 74.2 million yuan in 2019 to 125.9 million yuan in 2022, but net profit decreased from 27.7 million yuan to 21.8 million yuan during the same period [3][5]. - In 2023, the company achieved revenue of 1.451 billion yuan and net profit of 254 million yuan, with a projected revenue decline to 1.391 billion yuan in 2024, although net profit is expected to grow by 23.97% [3][5]. Group 2: Challenges and Strategic Moves - The company has faced challenges in its core membrane technology business, with profits increasingly reliant on government subsidies and non-recurring gains, which accounted for 18% of net profit in 2024 [5][7]. - Sanda Membrane's four major fundraising projects have not been completed as planned, raising concerns about the efficiency of capital use [5][7]. - The company is diversifying into the renewable energy sector, securing lithium extraction orders worth 366 million yuan in 2022, which constituted 29% of its revenue that year [5][6]. Group 3: H-share Listing Motivation - The decision to pursue an H-share listing is seen as a strategic move to alleviate funding pressures for new projects and international expansion, particularly in Southeast Asia [7][8]. - The company has a significant amount of cash on hand (1.36 billion yuan) but faces rising accounts receivable, which exceeded 900 million yuan in 2024, representing over 60% of revenue [7][8]. - The H-share listing is expected to attract international long-term capital and improve the company's governance structure, especially in light of management changes [9][10]. Group 4: Market Perception and Future Outlook - There is a misalignment in market perception, with investors viewing Sanda Membrane primarily as a water treatment company rather than a comprehensive membrane technology enterprise [10]. - The H-share listing could serve as an opportunity to reshape this perception and attract international investors, potentially stabilizing the company's valuation [10][11]. - The company's international ambitions, particularly in addressing industrial wastewater treatment needs in Southeast Asia and the Middle East, align with its strategic goals [8][9].

Group 1 - Company Xi Zhong Technology proposed to repurchase shares worth between 75 million and 150 million yuan using excess funds and self-owned funds [1] - Company Yongxi Electronics expects a revenue growth of 16.6% to 28.88% in the first half of the year, with projected revenue between 1.9 billion and 2.1 billion yuan [2] - Company Jingyi Equipment anticipates a revenue increase of 36.54% to 42.48%, with expected revenue between 690 million and 720 million yuan [2][3] Group 2 - Company Haipuri received approval from the European Medicines Agency (EMA) for a new production line for Enoxaparin Sodium injection, with an annual capacity of 330 million doses [4] - Company Inner Mongolia Xinhua plans to merge its wholly-owned subsidiaries to optimize resource allocation and improve operational efficiency [5] - Company Cloud Chemical intends to sign daily related transaction framework agreements with its controlling shareholder to reduce operational costs [7] Group 3 - Company China Software received approval from the China Securities Regulatory Commission for a specific stock issuance [8] - Company Wankong Intelligent's subsidiary won a bid for a project with the State Grid worth approximately 12.17 million yuan [9] - Company Lianlong obtained a patent for an anti-aging agent, which is expected to enhance its product offerings in polymer materials [11] Group 4 - Company Yunlu plans to increase its shares by 4 million to 12 million yuan through stock purchases by its executives [12] - Company Enhua Pharmaceutical's chairman increased his stake by 237,900 shares [14] - Company Daqin Railway announced the resignation of its general manager due to retirement [15] Group 5 - Company Hefei Urban Construction signed a land use rights transfer contract for an industrial site with an area of 78,561.78 square meters, with a payment of 103 million yuan due by July 13, 2025 [16] - Company Taiji Group received a government subsidy of 20 million yuan, representing 75.04% of its projected net profit for 2024 [17] - Company Guodian Nanrui elected a new chairman, Zheng Zongqiang, while he resigned from his previous roles [19] Group 6 - Company Xinhua Medical received a medical device registration certificate for a thromboelastography testing kit [20] - Company Baotailong's subsidiary obtained a mining license for a graphite mine with a production capacity of 2 million tons per year [21] - Company Zejing Pharmaceutical received approval for clinical trials of its innovative cancer treatment drugs [22] Group 7 - Company Aojing Medical's artificial bone repair material received registration approval in Vietnam [23] - Company Chengjian Development received a cash dividend of 90.2169 million yuan from Guoxin Securities [24] - Company Rili Technology proposed a share repurchase plan worth between 10 million and 20 million yuan [25] Group 8 - Company Deshi General Institute received approval to issue up to 1 billion yuan in technology innovation bonds [44] - Company Tongding Interconnect plans to bid for two procurement projects worth approximately 717 million yuan [46] - Company Bangji Technology plans to acquire multiple agricultural companies [46]

Group 1 - The concept stocks related to nuclear pollution prevention have seen a significant rise, with Jihua Group hitting the daily limit up [1] - China Nuclear Technology previously reached the daily limit up, indicating strong market interest [1] - Other companies such as Jieqiang Equipment and China General Nuclear Power Technology have increased by over 5% [1] Group 2 - Additional stocks that experienced gains include Sandam Membrane, China Electric Environmental Protection, Construction Repair, and Beihua Co., Ltd [1]

Group 1 - The company announced plans to initiate the process for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its international presence and brand recognition [1] - The board of directors has authorized the management to start preparatory work for the H-share listing, with a timeframe of 12 months from the board's approval [1] - The H-share listing is subject to further approval from the board, shareholders, and relevant regulatory bodies including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1] Group 2 - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 15, 2019, with an issuance of 83.47 million shares at a price of 18.26 yuan per share [2] - The total funds raised from the initial public offering amounted to 152.42 million yuan, with a net amount of 145.02 million yuan after deducting issuance costs [2] - The funds raised were intended for various projects including the production line for inorganic ceramic nanofiltration membranes and a research center for membrane materials and technology [2][3]

Key Points - The National Medical Products Administration plans to complete the review and approval of clinical trial applications for innovative drugs that meet requirements within 30 working days [4] - The U.S. and U.K. have reached a trade agreement, which includes a quota of 100,000 vehicles per year for U.S. imports from the U.K. with a 10% tariff rate [6] - The U.S. President Trump announced a temporary suspension of sanctions against Russia to facilitate negotiations [6] - The industrial added value in China increased by 5.8% year-on-year in May, while the retail sales of consumer goods reached 41,326 billion yuan, growing by 6.4% year-on-year [4] Company News - GAC Group denied rumors regarding employee stock ownership related to GAC Aion [9] - Midea Group plans to repurchase shares worth between 5 billion to 10 billion yuan [9] - Chongqing Steel signed an asset transfer contract worth 1.081 billion yuan with Chongqing Iron and Steel Group [9] - Muyuan Foods has submitted H-share filing materials to the China Securities Regulatory Commission [9] - Weir Group's stock name will change to "Haowei Group" starting June 20 [9] - LaKala is planning to issue H-shares and list on the Hong Kong Stock Exchange [9] - China Bank's Vice President Zhang Xiaodong has left due to job relocation [9] Industry Insights - CITIC Securities has received approval to issue up to 6 billion yuan in technology innovation bonds [10] - Huatai Securities has received registration approval from the CSRC for issuing up to 10 billion yuan in technology innovation corporate bonds [10] - Huatai Securities is optimistic about the home appliance sector, highlighting the strong demand for core assets and the potential for overseas market expansion [11] - CITIC Securities predicts a price increase of 5%-10% in the wind turbine sector by 2025, indicating a new profit recovery cycle for the industry [12]

Group 1: Stock Resumption - Bohai Automobile plans to acquire 51% equity in Beiqi Moulding, 51% equity in Langfang Andotuo, 100% equity in Zhilian Technology, and 50% equity in Laini Wiring Harness, with stock resuming trading tomorrow [1] - Bangji Technology intends to purchase 100% equity in Beixi Agriculture, Ruido Weili, Xinmu Agriculture, Ruido Agriculture (Lijin), Ruido Agriculture (Shandong), and Weili Agriculture (Binzhou), as well as 80% equity in Paistong through issuing shares and cash payment, with stock resuming trading [1] Group 2: Mergers and Acquisitions - Taihe Intelligent plans to acquire 100% equity in Sunshine Yuchu for no more than 50 million, aiming to expand its energy storage business for commercial users [2] - Wuzhou Xinchun intends to raise no more than 1 billion for the research and industrialization of embodied intelligent robots and core components for automotive intelligent driving [2] Group 3: Share Buybacks - Zhongtong Bus has initiated its first share buyback of 2 million shares [3] - Midea Group plans to repurchase shares worth between 5 billion to 10 billion [6] Group 4: Investment Cooperation and Business Status - Jiangbolong's subsidiary has signed a cooperation memorandum with SanDisk, a globally recognized storage solutions provider with leading storage technology and extensive system design experience [5] - Dazhu CNC has had its application materials for overseas listing shares accepted by the China Securities Regulatory Commission [7] - SanDa Membrane plans to issue H-shares and list on the Hong Kong Stock Exchange [7] - Xinqi Eye Medicine has enrolled the first subject in the Phase III clinical trial for lidocaine eye gel [7] - Shanshui Technology intends to invest 6 billion in a new chemical materials project [7] - China Energy Construction's subsidiary consortium has won a 5 billion EPC general contracting project [7] - Fudan Zhangjiang's injectable FZ-P001 sodium for visualizing malignant lesions during cancer surgery has received clinical trial application acceptance [7] - Yiyuan Lithium Energy plans to extend the reduction of 3.5% shares in Simor International [7] - Lakala is planning to list on the Hong Kong Stock Exchange to accelerate the application of digital currency in cross-border scenarios [7] - Jintaiyang intends to cancel 1.7692 million shares and reduce registered capital accordingly [8] - Aiwei Electronics has developed a low-power high-voltage piezoelectric micro-pump liquid cooling product, marking a breakthrough in domestic chip technology in this field [8] - Redik plans to acquire investment fund shares worth 40 million, focusing on strengthening technology reserves for key components like robotic joint modules [9]

三达膜环境技术股份有限公司 章 程 二零二五年六月 | 第- 一章 总 则 . . | | --- | | 第二章 经营宗旨和范围. | | 第三章 股 份 . | | 第一节 股份发行 . | | 第二节 股份增减和回购 | | 第三节 股份转让 . | | 第四章 股东和股东大会 . | | 第一节 股东 . | | 第二节 股东大会的一般规定 | | 第三节 股东大会的召集 14 | | 第四节 股东大会的提案与通知 15 | | 第五节 股东大会的召开 | | 第六节 股东大会的表决和决议 . | | 第五章 董事会 | | 第一节 董事 . | | 第二节 独立董事 . | | 第三节 董事会 | | 第六章 总经理及其他高级管理人员. | | 第七章 监事会 | | 第一节 监事 . | | | | 第一章 总 则 第一条 为维护公司、股东和债权人的合法权益，规范公司的组织和行为， 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和国证券 法》（以下简称"《证券法》"）《上市公司章程指引》《上市公司治理准则》《上海 证券交易所科创板股票上市规则》等法律、法规和规范性文件的有关规定 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 证券代码：688101 证券简称：三达膜 公告编号：2025-031 三达膜环境技术股份有限公司 关于授权公司管理层启动公司境外发行股份（H 股） 并在香港联合交易所有限公司上市相关筹备工作的公告 董事会 2025 年 6 月 17 日 三达膜环境技术股份有限公司（以下简称"公司"）于 2025 年 6 月 16 日召开第五届董事会第六次会议，审议通过了《关于授权公司管 理层启动公司境外发行股份（H 股）并在香港联合交易所有限公司上市 相关筹备工作的议案》，现将相关事项公告如下： 为加快构建公司国内国际双循环格局，推进公司海外战略布局， 进一步提升公司品牌形象及知名度，提高公司的资本实力和综合竞争 力，根据公司总体发展战略及运营需要，公司拟在境外发行股份（H 股）并在香港联合交易所有限公司（以下简称"香港联交所"）上市 （以下简称"本次 H 股上市"）。公司董事会同意授权公司管理层启 动本次 H 股上市的前期筹备工作，授权期限为自董事会审议通过之日 起 12 个月内。公司计 ...

三达膜环境技术股份有限公司 证券代码：688101 证券简称：三达膜 公告编号：2025-030 二、《公司章程》部分条款的修订情况 基于公司拟增加经营范围的情况，根据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司章程指引》《上海证券交易所科创 板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等法律、法规及规范性文件的有关规定，公司董事会 拟对《公司章程》进行修订，具体修订内容如下： | 序号 | 修订前 | 修订后 | | --- | --- | --- | | | 第十四条 公司经营范围是：环 | 第十四条 公司经营范围是：环境保护与 | | | 境保护与资源综合利用工程设 | 资源综合利用工程设计与施工；各类工程 | | | 计与施工；各类工程建设活动； | 建设活动；环境保护与资源综合利用技术 | | | 环境保护与资源综合利用技术 | 与设备的开发、设计、制造及安装；经营 | | 1 | 与设备的开发、设计、制造及安 | 各类商品和技术的进出口（不另附进出 | | | 装（所从事经营项目中，需取得 | 口商品目录），但国家限定公司经营或禁 | | | ...